A

Axial Therapeutics, Inc.

25 employees

Axial Therapeutics is a clinical stage biopharmaceutical company harnessing the gut-brain axis to develop novel Central Nervous System.

Basic info

biotechnology research

Biotechnology

small molecule

Medical

Pharmaceutical

Neurological disorders and diseases

Biopharma

autism

parkinson's disease

gut-brain axis

2016

$37M

from 15 investors over 15 rounds

A

Axial Therapeutics, Inc. raised $37M on October 13, 2021

Investors: Autism Impact Fund, OneVentures, UTokyo Innovation Platform Co., Ltd., Corundum Systems Biology, Longwood Fund and Domain Associates

A

Axial Therapeutics, Inc. raised $25M on February 27, 2019

Investors: Seventure Partners, Domain Associates and Longwood Fund

A

Axial Therapeutics, Inc. raised $19M on December 1, 2016

Investors: Domain Associates, Longwood Fund and Kairos Ventures

A

Axial Therapeutics, Inc. raised $20M on November 30, 2016

Investors: Longwood Fund, Domain Associates and Kairos Ventures